44 related articles for article (PubMed ID: 17680662)
21. Effect of permeability enhancers on paracellular permeability of acyclovir.
Ates M; Kaynak MS; Sahin S
J Pharm Pharmacol; 2016 Jun; 68(6):781-90. PubMed ID: 27061718
[TBL] [Abstract][Full Text] [Related]
22. Discovery of synergistic permeation enhancers for oral drug delivery.
Whitehead K; Karr N; Mitragotri S
J Control Release; 2008 Jun; 128(2):128-33. PubMed ID: 18433909
[TBL] [Abstract][Full Text] [Related]
23. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Thanou M; Henderson S; Kydonieus A; Elson C
J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers.
Petersen SB; Nolan G; Maher S; Rahbek UL; Guldbrandt M; Brayden DJ
Eur J Pharm Sci; 2012 Nov; 47(4):701-12. PubMed ID: 22952065
[TBL] [Abstract][Full Text] [Related]
25. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
[TBL] [Abstract][Full Text] [Related]
26. Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery.
Cano-Cebrián MJ; Zornoza T; Granero L; Polache A
Curr Drug Deliv; 2005 Jan; 2(1):9-22. PubMed ID: 16305404
[TBL] [Abstract][Full Text] [Related]
27. Chitosan and its derivatives as intestinal absorption enhancers.
Thanou M; Verhoef JC; Junginger HE
Adv Drug Deliv Rev; 2001 Oct; 50 Suppl 1():S91-101. PubMed ID: 11576697
[TBL] [Abstract][Full Text] [Related]
28. Polymeric enhancers of mucosal epithelia permeability: synthesis, transepithelial penetration-enhancing properties, mechanism of action, safety issues.
Di Colo G; Zambito Y; Zaino C
J Pharm Sci; 2008 May; 97(5):1652-80. PubMed ID: 17828745
[TBL] [Abstract][Full Text] [Related]
29. [Advances in the study of excipient inhibitors of intestinal P-glycoprotein].
Yan F; Si LQ; Huang JG; Li G
Yao Xue Xue Bao; 2008 Nov; 43(11):1071-6. PubMed ID: 19239022
[TBL] [Abstract][Full Text] [Related]
30. Assessing the absorption of new pharmaceuticals.
Hidalgo IJ
Curr Top Med Chem; 2001 Nov; 1(5):385-401. PubMed ID: 11899104
[TBL] [Abstract][Full Text] [Related]
31. Intestinal permeation enhancers: Lessons learned from studies using an organ culture model.
Danielsen EM
Biochim Biophys Acta Biomembr; 2021 Jan; 1863(1):183474. PubMed ID: 32946886
[TBL] [Abstract][Full Text] [Related]
32. Improving oral drug bioavailability with polycations?
Schulz JD; Gauthier MA; Leroux JC
Eur J Pharm Biopharm; 2015 Nov; 97(Pt B):427-37. PubMed ID: 26614561
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of surfactant effects on drug absorption.
Gibaldi M; Feldman S
J Pharm Sci; 1970 May; 59(5):579-89. PubMed ID: 4911055
[No Abstract] [Full Text] [Related]
34. Ganciclovir.
Al-Badr AA; Ajarim TDS
Profiles Drug Subst Excip Relat Methodol; 2018; 43():1-208. PubMed ID: 29678260
[TBL] [Abstract][Full Text] [Related]
35. Intestinal drug absorption enhancement: an overview.
van Hoogdalem EJ; de Boer AG; Breimer DD
Pharmacol Ther; 1989; 44(3):407-43. PubMed ID: 2519349
[No Abstract] [Full Text] [Related]
36. Physical methods for enhancing drug absorption from the gastrointestinal tract.
Luo Z; Paunović N; Leroux JC
Adv Drug Deliv Rev; 2021 Aug; 175():113814. PubMed ID: 34052229
[TBL] [Abstract][Full Text] [Related]
37. Intestinal permeation enhancers.
Aungst BJ
J Pharm Sci; 2000 Apr; 89(4):429-42. PubMed ID: 10737905
[TBL] [Abstract][Full Text] [Related]
38. Improvement of drug absorption through enhancers.
de Boer AG; van Hoogdalem EJ; Breimer DD
Eur J Drug Metab Pharmacokinet; 1990; 15(2):155-7. PubMed ID: 2200684
[TBL] [Abstract][Full Text] [Related]
39. Modulation of ganciclovir intestinal absorption in presence of absorption enhancers.
Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
J Pharm Sci; 2007 Oct; 96(10):2710-22. PubMed ID: 17680662
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
